Florida International University
Edit Your Profile
FIU Discovery
Toggle navigation
Browse
Home
People
Organizations
Scholarly & Creative Works
Research Facilities
Support
Ng, Hooi Hooi
Profile QR Code
Share this page
Twitter
Email
Copy link
Share
Publications
Research
View All
Publications
Patents issued
Materials and Methods for the Treatment of Vascular Calcification
Patent
Targeting Epidermal Growth Factor to Treat Vascular Calcification
Patent
selected scholarly works & creative activities
Article
2022
The Time-Dependent Role of Bisphosphonates on Atherosclerotic Plaque Calcification
.
Journal of Cardiovascular Development and Disease
. 9.
Full Text via DOI:
10.3390/jcdd9060168
Web of Science:
000816404400001
2022
S2 Heart Sound Detects Aortic Valve Calcification Independent of Hemodynamic Changes in Mice
.
Frontiers in Cardiovascular Medicine
. 9.
Full Text via DOI:
10.3389/fcvm.2022.809301
Web of Science:
000807820700001
2021
Abstract 14001: Using the S2 Sound as an Early Marker of Aortic Valve Calcification
.
Circulation
. 144:a14001-a14001.
Full Text via DOI:
10.1161/circ.144.suppl_1.14001
2021
Anti-apoptotic and Matrix Remodeling Actions of a Small Molecule Agonist of the Human Relaxin Receptor, ML290 in Mice With Unilateral Ureteral Obstruction
.
Frontiers in Physiology
. 12.
Full Text via DOI:
10.3389/fphys.2021.650769
Web of Science:
000674951600001
2021
Tracking Acoustic and Electrophysiological Changes Associated with CKD-induced Cardiac and Valvular Remodeling in a Mouse Model
.
Structural Heart
. 5:23.
Full Text via DOI:
10.1080/24748706.2021.1901527
2020
Abstract 17021: A Novel Human Relaxin Receptor Agonist, ML290, Attenuates Atherosclerosis- and Chronic Kidney Disease-Induced Vascular Calcification in Mice
.
Circulation
. 142.
Full Text via DOI:
10.1161/circ.142.suppl_3.17021
2020
Annexin-A1 deficiency exacerbates pathological remodelling of the mesenteric vasculature in insulin-resistant, but not insulin-deficient, mice
.
British Journal of Pharmacology
. 177:1677-1691.
Full Text via DOI:
10.1111/bph.14927
Web of Science:
000512355800001
2020
Relaxin reduces endothelium-derived vasoconstriction in hypertension: Revealing new therapeutic insights
.
British Journal of Pharmacology
. 177:217-233.
Full Text via DOI:
10.1111/bph.14858
Web of Science:
000493438200001
2019
Therapeutic effects of a small molecule agonist of the relaxin receptor ML290 in liver fibrosis
.
The FASEB Journal
. 33:12435-12446.
Full Text via DOI:
10.1096/fj.201901046R
Web of Science:
000507461600065
2019
Relaxin and extracellular matrix remodeling: Mechanisms and signaling pathways
.
Molecular and Cellular Endocrinology
. 487:59-65.
Full Text via DOI:
10.1016/j.mce.2019.01.015
Web of Science:
000463350300010
2019
Small molecule allosteric agonist of relaxin receptor ML290 demonstrates antifibrotic properties in liver fibrosis
.
Endocrine Abstracts
.
Full Text via DOI:
10.1530/endoabs.63.gp223
2019
Targeting the relaxin/insulin-like family peptide receptor 1 and 2 with small molecule compounds
.
Molecular and Cellular Endocrinology
. 487:40-44.
Full Text via DOI:
10.1016/j.mce.2018.12.013
Web of Science:
000463350300007
2019
SAT-035 Small Molecule Allosteric Agonist of Relaxin Receptor Ml290 Demonstrates Antifibrotic Properties in Liver Fibrosis
.
Journal of the Endocrine Society
. 3:sat-035.
Full Text via DOI:
10.1210/js.2019-sat-035
2019
Recent developments in relaxin mimetics as therapeutics for cardiovascular diseases
.
Current Opinion in Pharmacology
. 45:42-48.
Full Text via DOI:
10.1016/j.coph.2019.04.001
Web of Science:
000483006200007
2017
Endothelial dysfunction in the aorta of non-pregnant relaxin-deficient mice is not observed in pregnancy
.
Placenta
. 57:272.
Full Text via DOI:
10.1016/j.placenta.2017.07.158
2017
Chronic NaHS treatment decreases oxidative stress and improves endothelial function in diabetic mice
.
Diabetes and Vascular Disease Research
. 14:246-253.
Full Text via DOI:
10.1177/1479164117692766
2017
Serelaxin treatment reduces oxidative stress and increases aldehyde dehydrogenase-2 to attenuate nitrate tolerance
.
Frontiers in Pharmacology
. 8.
Full Text via DOI:
10.3389/fphar.2017.00141
2017
1,4-Anhydro-4-seleno-D-talitol (SeTal) protects endothelial function in the mouse aorta by scavenging superoxide radicals under conditions of acute oxidative stress
.
Biochemical Pharmacology
. 128:34-45.
Full Text via DOI:
10.1016/j.bcp.2016.12.019
2017
Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes
.
Scientific Reports
. 7.
Full Text via DOI:
10.1038/srep39604
2017
B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin)
.
European Journal of Pharmacology
. 807:190-197.
Full Text via DOI:
10.1016/j.ejphar.2017.05.005
2016
Adverse vascular remodelling is more sensitive than endothelial dysfunction to hyperglycaemia in diabetic rat mesenteric arteries
.
Pharmacological Research
. 111:325-335.
Full Text via DOI:
10.1016/j.phrs.2016.06.025
2016
Serelaxin (recombinant human relaxin-2) prevents high glucose-induced endothelial dysfunction by ameliorating prostacyclin production in the mouse aorta
.
Pharmacological Research
. 107:220-228.
Full Text via DOI:
10.1016/j.phrs.2016.03.011
2016
Time-dependent activation of prostacyclin and nitric oxide pathways during continuous i.v. infusion of serelaxin (recombinant human H2 relaxin)
.
British Journal of Pharmacology
. 173:1005-1017.
Full Text via DOI:
10.1111/bph.13404
2015
Increased superoxide production and altered nitric oxide-mediated relaxation in the aorta of young but not old male relaxin-deficient mice
.
American Journal of Physiology. Heart and Circulatory Physiology
. 309:H285-H296.
Full Text via DOI:
10.1152/ajpheart.00786.2014
2014
Hydrogen sulfide protects endothelial nitric oxide function under conditions of acute oxidative stress in vitro.
.
Naunyn-Schmiedeberg's Archives of Pharmacology
. 387:67-74.
Full Text via DOI:
10.1007/s00210-013-0920-x
2013
OP15 Hydrogen sulfide protects endothelial function under conditions of oxidative stress
.
Nitric Oxide - Biology and Chemistry
. 31:s25.
Full Text via DOI:
10.1016/j.niox.2013.06.045
Book Chapter
2020
Calcifying Extracellular Vesicles: Biology, Characterization, and Mineral Formation
. 97-116.
Full Text via DOI:
10.1007/978-3-030-46725-8_5
Conference
2020
Therapeutic Effects of a Small Molecule Agonist of the Relaxin Receptor in Mice with Unilateral Ureteral Obstruction
.
The FASEB Journal
.
Full Text via DOI:
10.1096/fasebj.2020.34.s1.09260
Web of Science:
000546107900377
Other Scholarly Work
2021
A Biased Relaxin Receptor Agonist, ML290, Attenuates Atherosclerotic Calcification in Apolipoprotein E-deficient Mice
.
The FASEB Journal
.
Full Text via DOI:
10.1096/fasebj.2021.35.S1.02926
Web of Science:
000669893102336
2013
Hydrogen sulfide as a vasculoprotective factor.
.
Medical Gas Research
. 9.
Full Text via DOI:
10.1186/2045-9912-3-9
Preprint
2022
Time-dependent Role of Bisphosphonates on Atherosclerotic Plaque Calcification
Full Text via DOI:
10.1101/2022.02.14.479950
2021
Epidermal Growth Factor Receptor Inhibition Prevents Caveolin-1-dependent Calcifying Extracellular Vesicle Biogenesis
Full Text via DOI:
10.1101/2021.11.08.467799
Review
2018
Relaxin as a Therapeutic Target for the Cardiovascular Complications of Diabetes
.
Frontiers in Pharmacology
.
Full Text via DOI:
10.3389/fphar.2018.00501
Web of Science:
000432304100001
2017
Vascular actions of relaxin: nitric oxide and beyond
.
British Journal of Pharmacology
. 1002-1014.
Full Text via DOI:
10.1111/bph.13614
2016
Serelaxin: A Novel Therapeutic for Vascular Diseases
.
Trends in Pharmacological Sciences
. 498-507.
Full Text via DOI:
10.1016/j.tips.2016.04.001
Research
principal investigator on
Small Molecule Agonist of the Human Relaxin Receptor for Treatment of Vascular Calcification
awarded by
FIU Foundation
2020 - 2021
Targeting relaxin receptor for the treatment of diabetes-induced cardiovascular calcification
awarded by
American Heart Association
2019 - 2020
subproject principal investigator on
Targeting the oxidative signaling pathway in vascular calcification
awarded by
Florida Heart Research Foundation Inc
2021 - 2023
visualizations
Co-author Network
Co-investigator Network
Map of Science